Drugmaker Opexa says their experimental drug Tovaxin helped 83 percent of patients with relapsing remitting multiple sclerosis remain relapse free after a year.

The new information warns patients that the risk of progressive multifocal leukoencephalopathy, or PML, appears to increase as the number of Tysabri infusions increase.

A new drug called atacicept that is being developed to treat rheumatoid arthritis has failed to meet its goals in mid-stage clinical trials, its maker reports.

A reporter discusses the best ways to navigate the sea of medical-billing red tape.

A reporter discusses the best ways to navigate the sea of medical-billing red tape.

Research shows inflammation link between two disorders.

British researchers say a simple blood test may soon help ease anxiety related to a new MS diagnosis.